Moneycontrol Presented by Motilal Oswal
Days hours minutes
Nerolac
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance
Indiabulls
DHFL

Co-Presenting Sponsor

Capital Trade

Powered by

Godrej

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
Oct 13, 2017 06:22 PM IST | Source: Moneycontrol.com

Torrent Pharmaceuticals Q2 PAT seen up 13.9% YoY to Rs. 235.7 cr: Kotak

Net Sales are expected to increase by 9.2 percent Y-o-Y (up 13.6 percent Q-o-Q) to Rs. 1560.8 crore, according to Kotak.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Kotak has come out with its second quarter (July-September) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Torrent Pharmaceuticals to report net profit at Rs. 235.7 crore up 13.9% year-on-year (25.4% quarter-on-quarter).


Net Sales are expected to increase by 9.2 percent Y-o-Y (up 13.6 percent Q-o-Q) to Rs. 1560.8 crore, according to Kotak.


Earnings before interest, tax, depreciation and amortization (EBITDA) are likely to rise by 6.1 percent Y-o-Y (up 17.9 percent Q-o-Q) to Rs. 350.1 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Sections
Follow us on
Available On